Omeros Corporation
OMER
$3.15
Share price
2.94%
Change (1 day)
-43.65%
Change (1 year)
Categories
Earnings for Omeros Corporation (OMER)
Earnings in 2023 (TTM): -$0.15 B
According to Omeros Corporation's latest financial reports the company's current earnings (TTM) are -$0.15 B. In 2022 the company made an earning of -$0.16 B an increase over its 2021 earnings that were of -$0.23 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Omeros Corporation from 2009 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.15 B | -5.86% |
| 2022 | -$0.16 B | -30.65% |
| 2021 | -$0.23 B | 86.28% |
| 2020 | -$0.13 B | 99.45% |
| 2019 | -$61.83 M | -49.91% |
| 2018 | -$0.13 B | 190.77% |
| 2017 | -$42.46 M | -27.96% |
| 2016 | -$58.93 M | -17.61% |
| 2015 | -$71.53 M | 1.88% |
| 2014 | -$70.21 M | 87.56% |
| 2013 | -$37.43 M | |
| 2011 | -$27.41 M | -8.96% |
| 2010 | -$30.11 M | 45.03% |
| 2009 | -$20.76 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -11,414.89% | 🇺🇸 USA |
 Pfizer PFE | $3.26 B | -2,278.04% | 🇺🇸 USA |
 Genetic Technologies GENE | -$3.8 M | -97.47% | 🇦🇺 Australia |
 Eterna Therapeutics ERNA | -$20.53 M | -86.32% | 🇺🇸 USA |